Personalized Brachytherapy for a Herlyn-Werner-Wunderlich Syndrome Patient with Endometrial Cancer: A Case Report

References

• Oaknin A, Bosse TJ, Creutzberg CL, et al. Endometrial cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022;33(9):860–877. doi:10.1016/j.annonc.2022.05.009
   PubMed Web of Science ®Google Scholar
• Zakem SJ, Robin TP, Smith DE, et al. Evolving trends in the management of high-intermediate risk endometrial cancer in the United States. Gynecol Oncol. 2019;152(3):522–527. doi:10.1016/j.ygyno.2018.12.010
   PubMed Web of Science ®Google Scholar
• Harkenrider MM, Grover S, Erickson BA, et al. Vaginal brachytherapy for postoperative endometrial cancer: 2014 survey of the American brachytherapy society. Brachytherapy. 2016;15(1):23–29. doi:10.1016/j.brachy.2015.09.012
   PubMed Web of Science ®Google Scholar
• Hou X, Liu A, Zhang F, Wong J, Chen YJ. Dosimetric advantages of using multichannel balloons compared to single-channel cylinders for high-dose-rate vaginal cuff brachytherapy. Brachytherapy. 2016;15(4):471–476. doi:10.1016/j.brachy.2016.03.002
   PubMedGoogle Scholar
• Yan J, Qin X, Zhang F, Hou X, Yu L, Qiu J. Comparing multichannel cylinder and 3D-printed applicators for vaginal cuff brachytherapy with preliminary exploration of post-hysterectomy vaginal morphology. J Contemp Brachytherapy. 2021;13(6):641–648. doi:10.5114/jcb.2021.112115
   PubMed Web of Science ®Google Scholar
• Wiebe E, Easton H, Thomas G, Barbera L, D’Alimonte L, Ravi A. Customized vaginal vault brachytherapy with computed tomography imaging-derived applicator prototyping. Brachytherapy. 2015;14(3):380–384. doi:10.1016/j.brachy.2014.12.006
   PubMed Web of Science ®Google Scholar
• Horst W, de Melo RC, Theilacker G, Schmitt B, de Melo RC. Herlyn-Werner-Wunderlich syndrome: clinical considerations and management. BMJ Case Rep. 2021;14(3):e239160. doi:10.1136/bcr-2020-239160
   PubMedGoogle Scholar
• Tong J, Zhu L, Lang J. Clinical characteristics of 70 patients with Herlyn-Werner-Wunderlich syndrome. Int J Gynaecol Obstet. 2013;121(2):173–175. doi:10.1016/j.ijgo.2012.11.023
   PubMed Web of Science ®Google Scholar
• Hermens M, van Altena AM, Velthuis I, et al. Endometrial cancer incidence in endometriosis and adenomyosis. Cancers. 2021;13(18):4592. doi:10.3390/cancers13184592
   PubMed Web of Science ®Google Scholar
• Nout, RA, Smit, V, Putter, H, et al Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet. 2010;375(9717):816-823. doi:10.1016/S0140-6736(09)62163-2.
   Google Scholar
• Wortman BG, Creutzberg CL, Putter H, et al. Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy. Br J Cancer. 2018;119(9):1067–1074. doi:10.1038/s41416-018-0310-8
   PubMed Web of Science ®Google Scholar
• Bingham B, Orton A, Boothe D, et al. Brachytherapy improves survival in stage III endometrial cancer with cervical involvement. Int J Radiat Oncol Biol Phys. 2017;97(5):1040–1050. doi:10.1016/j.ijrobp.2016.12.035
   PubMed Web of Science ®Google Scholar
• Rossi PJ, Jani AB, Horowitz IR, Johnstone PA. Adjuvant brachytherapy removes survival disadvantage of local disease extension in stage IIIC endometrial cancer: a SEER registry analysis. Int J Radiat Oncol Biol Phys. 2008;70(1):134–138. doi:10.1016/j.ijrobp.2007.05.048
   PubMed Web of Science ®Google Scholar
• Bogani G, Ray-Coquard I, Concin N, et al. Uterine serous carcinoma. Gynecol Oncol. 2021;162(1):226–234. doi:10.1016/j.ygyno.2021.04.029
   PubMed Web of Science ®Google Scholar
• Hong JC, Foote J, Broadwater G, Gaillard S, Havrilesky LJ, Chino JP. Impact of chemotherapy and radiotherapy on management of early stage clear cell and papillary serous carcinoma of the uterus. Int J Gynecol Cancer. 2017;27(4):720–729. doi:10.1097/IGC.0000000000000926
   PubMed Web of Science ®Google Scholar
• Kamrava M, Alrashidi SM, Leung E. Interstitial brachytherapy for gynecologic malignancies: complications, toxicities, and management. Brachytherapy. 2021;20(5):995–1004. doi:10.1016/j.brachy.2020.12.008
   PubMed Web of Science ®Google Scholar
• Prisciandaro JI, Zhao X, Dieterich S, Hasan Y, Jolly S, Al-Hallaq HA. Interstitial high-dose-rate gynecologic brachytherapy: clinical workflow experience from three academic institutions. Semin Radiat Oncol. 2020;30(1):29–38. doi:10.1016/j.semradonc.2019.08.001
   PubMed Web of Science ®Google Scholar
• Hassouna A, Bahadur YA, Constantinescu C. Assessment of air pockets in high-dose-rate vaginal cuff brachytherapy using cylindrical applicators. J Contemp Brachytherapy. 2014;6(3):271–275. doi:10.5114/jcb.2014.45436
   PubMed Web of Science ®Google Scholar
• Lindegaard JC, Madsen ML, Traberg A, et al. Individualised 3D printed vaginal template for MRI guided brachytherapy in locally advanced cervical cancer. Radiother Oncol. 2016;118(1):173–175. doi:10.1016/j.radonc.2015.12.012
   PubMed Web of Science ®Google Scholar
• Mohammadi R, Siavashpour Z, Aghdam SRH, Fazli S, Major T, Rohani AA. Manufacturing and evaluation of multi-channel cylinder applicator with 3D printing technology. J Contemp Brachytherapy. 2021;13(1):80–90. doi:10.5114/jcb.2021.103590
   PubMed Web of Science ®Google Scholar
• Fokdal L, Tanderup K, Nielsen SK, et al. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept. Radiother Oncol. 2011;100(3):473–479. doi:10.1016/j.radonc.2011.08.016
   PubMed Web of Science ®Google Scholar
• Chapman CH, Prisciandaro JI, Maturen KE, et al. MRI-based evaluation of the vaginal cuff in brachytherapy planning: are we missing the target? Int J Radiat Oncol Biol Phys. 2016;95(2):743–750. doi:10.1016/j.ijrobp.2016.01.042
   PubMed Web of Science ®Google Scholar
• Westerveld H, Nesvacil N, Fokdal L, et al. Definitive radiotherapy with image-guided adaptive brachytherapy for primary vaginal cancer. Lancet Oncol. 2020;21(3):e157–e167. doi:10.1016/S1470-2045(19)30855-1
   PubMed Web of Science ®Google Scholar
• Viswanathan AN, Dimopoulos J, Kirisits C, Berger D, Potter R. Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours. Int J Radiat Oncol Biol Phys. 2007;68(2):491–498. doi:10.1016/j.ijrobp.2006.12.021
   PubMed Web of Science ®Google Scholar
• Schindel J, Muruganandham M, Pigge FC, Anderson J, Kim Y. Magnetic resonance imaging (MRI) markers for MRI-guided high-dose-rate brachytherapy: novel marker-flange for cervical cancer and marker catheters for prostate cancer. Int J Radiat Oncol Biol Phys. 2013;86(2):387–393. doi:10.1016/j.ijrobp.2012.12.026
   PubMed Web of Science ®Google Scholar